Health Care [ 9/12 ] | Health Care Equipment & Supplies [ 46/76 ]
NASDAQ | Common Stock
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States.
It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions.
The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain.
It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke PhilipsN. V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC.
The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020.
ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 7, 24 | -0.16 Increased by +44.83% | -0.20 Increased by +20.00% |
| May 7, 24 | -0.16 Increased by +30.43% | -0.19 Increased by +15.79% |
| Mar 12, 24 | -0.19 Decreased by -5.56% | -0.20 Increased by +5.00% |
| Nov 9, 23 | -0.20 Decreased by -33.33% | -0.25 Increased by +20.00% |
| Aug 8, 23 | -0.29 Decreased by -61.11% | -0.19 Decreased by -52.63% |
| May 11, 23 | -0.23 Decreased by -35.29% | -0.18 Decreased by -27.78% |
| Mar 1, 23 | -0.18 Increased by +10.00% | -0.20 Increased by +10.00% |
| Nov 8, 22 | -0.15 Increased by +16.67% | -0.19 Increased by +21.05% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 24 | 7.86 M Increased by +32.07% | -4.41 M Increased by +37.49% | Decreased by -56.10% Increased by +52.67% |
| Mar 31, 24 | 7.64 M Increased by +40.60% | -4.15 M Increased by +23.11% | Decreased by -54.27% Increased by +45.31% |
| Dec 31, 23 | 6.81 M Increased by +31.62% | -4.62 M Decreased by -7.39% | Decreased by -67.83% Increased by +18.41% |
| Sep 30, 23 | 5.76 M Increased by +11.97% | -4.81 M Decreased by -27.19% | Decreased by -83.46% Decreased by -13.59% |
| Jun 30, 23 | 5.95 M Increased by +14.42% | -7.05 M Decreased by -60.20% | Decreased by -118.52% Decreased by -40.01% |
| Mar 31, 23 | 5.43 M Increased by +7.99% | -5.39 M Decreased by -33.00% | Decreased by -99.25% Decreased by -23.16% |
| Dec 31, 22 | 5.17 M Increased by +20.83% | -4.30 M Decreased by -3.66% | Decreased by -83.13% Increased by +14.21% |
| Sep 30, 22 | 5.15 M Increased by +12.51% | -3.78 M Increased by +5.00% | Decreased by -73.47% Increased by +15.56% |